Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,184	6,332	50,569	17,806	5,913
Short-Term Investments	5,250	340.19	360.19	745	2,113
Trading Asset Securities	2.19	1,886	2,856	5,866	5,692
Cash & Short-Term Investments	22,437	8,558	53,786	24,417	13,718
Cash Growth	162.17%	-84.09%	120.28%	77.99%	-62.08%
Accounts Receivable	10,582	7,726	8,174	10,153	12,406
Other Receivables	729.74	194.11	509.92	1,774	1,621
Receivables	12,772	8,760	15,884	16,978	17,127
Inventory	12,897	13,019	10,546	16,977	12,089
Prepaid Expenses	139.83	116.21	80.58	129.48	114.17
Other Current Assets	326.62	654.81	408.36	294.83	677.36
Total Current Assets	48,572	31,108	80,705	58,796	43,726
Property, Plant & Equipment	64,529	93,526	96,943	101,312	107,813
Long-Term Investments	1,659	9,416	11,001	22,675	10,904
Goodwill	1,601	2,858	2,858	4,150	4,119
Other Intangible Assets	1,829	2,381	2,980	3,081	3,850
Long-Term Accounts Receivable	83.93	-0	-	-	-
Long-Term Deferred Tax Assets	1,172	774.48	530.59	-	-
Long-Term Deferred Charges	5,030	9,020	9,701	8,622	7,879
Other Long-Term Assets	8,407	17,053	18,412	16,794	16,839
Total Assets	132,883	166,137	224,121	215,448	195,149
Accounts Payable	6,685	7,291	6,461	6,155	4,829
Accrued Expenses	700.15	755.32	718.82	496.54	656.63
Short-Term Debt	32,169	56,276	73,521	10,050	18,112
Current Portion of Long-Term Debt	1,556	12,766	3,747	32,120	120
Current Portion of Leases	1,234	77.56	171.09	185.44	147.81
Current Income Taxes Payable	-	-	-	-	334.75
Current Unearned Revenue	242.6	106.08	23.75	-	-
Other Current Liabilities	19,264	15,774	25,339	5,811	9,909
Total Current Liabilities	61,850	93,045	109,981	54,818	34,110
Long-Term Debt	4,352	4,862	9,450	31,650	40,228
Long-Term Leases	1,129	34.72	120.83	180.31	189.66
Long-Term Deferred Tax Liabilities	-	-	-	16.36	487.43
Other Long-Term Liabilities	2,112	2,852	9,833	27,615	2,249
Total Liabilities	69,444	104,151	132,262	116,744	80,410
Common Stock	18,779	18,779	18,779	9,446	3,775
Additional Paid-In Capital	133,428	133,401	133,434	107,271	92,050
Retained Earnings	-89,634	-91,892	-60,603	-18,969	19,027
Treasury Stock	-3,707	-3,707	-3,707	-3,160	-3,160
Comprehensive Income & Other	1,394	1,657	1,769	1,168	461.98
Total Common Equity	60,260	58,238	89,671	95,755	112,154
Minority Interest	471.81	1,355	2,188	2,949	2,584
Shareholders' Equity	63,440	61,986	91,859	98,704	114,738
Total Liabilities & Equity	132,883	166,137	224,121	215,448	195,149
Total Debt	40,440	74,015	87,009	74,186	58,797
Net Cash (Debt)	-18,003	-65,457	-33,224	-49,769	-45,079
Net Cash Per Share	-479.34	-1742.81	-1426.23	-2298.37	-2283.92
Filing Date Shares Outstanding	37.37	37.37	37.37	22.51	17.8
Total Common Shares Outstanding	37.37	37.37	37.37	22.51	21.36
Working Capital	-13,279	-61,937	-29,276	3,979	9,616
Book Value Per Share	1612.55	1558.42	2399.56	4254.76	5249.92
Tangible Book Value	56,830	52,998	83,832	88,524	104,185
Tangible Book Value Per Share	1520.74	1418.22	2243.32	3933.45	4876.90
Land	8,305	25,626	24,378	25,388	25,614
Buildings	47,255	52,384	52,053	50,835	52,013
Machinery	32,627	36,265	33,830	30,572	34,641
Construction In Progress	1,209	259.66	917.82	3,422	1,513

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.